Editor LSA

Penny Stock Buzz- Tranzbyte Corp (OTCMKTS: ERBB), BNP Paribas SA (ADR) (OTCMKTS: BNPQY), American Graphite Technologies Inc (OTCBB: AGIN), Titan Pharmaceuticals, Inc. (OTCBB: TTNP)

 

Lewes, DE -- (SBWIRE) -- 09/10/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Tranzbyte Corp (OTCMKTS: ERBB), BNP Paribas SA (ADR) (OTCMKTS: BNPQY), American Graphite Technologies Inc (OTCBB: AGIN), Titan Pharmaceuticals, Inc. (OTCBB: TTNP).

Tranzbyte Corp (OTCMKTS: ERBB) remained a bull for the day as it reported the upward momentum of +8.70%. The stock closed at $0.0025 after decreasing total volume of 21.56 million shares. So far, the company’s stock is down -39.02% in the three months period. In the last 6 months of trade it reported a decline of -63.24%.

Will ERBB Continue To Move Higher? Find Out Here

Tranzbyte Corporation operates medical marijuana retail dispensaries under the Altitude Organic Medicine brand name in California, Colorado, and Arizona.

BNP Paribas SA (ADR) (OTCMKTS: BNPQY) reported the gain of 1.50% and closed at $ 33.10 with the total traded volume of 38.713 shares. The stock's opening price was $ 32.89. The company has a total market capitalization of $ 81.16 billion.

The 52-week price range of the stock remained $23.52 - $34.13, while during last trade its worst hit was $32.80 and it gained its best price of $33.14. Turning to the company's last 5-day performance, it showed uptrend with an upsurge of 5.55%.

Will BNPQY Continue To Move Higher? Find Out Here

BNP Paribas SA provides a range of banking and financial services worldwide. Its retail banking business offers current accounts and other solutions in the areas of corporate financing and asset management; various banking, financial, and insurance products.

American Graphite Technologies Inc (OTCBB: AGIN) ended its day with the plunge of -14.00%. It was closed at the price of $0.215 after making its opening at $0.25. The stock traded during its last trading session with the total volume of 268.879 shares, as compared to its average volume of 193.355 shares.

During the previous session, the company’s minimum price was $0.21, while it scored its top level for the day at $0.25.

Will AGIN Get Buyers Even After The Recent Rally? Find Out Here

American Graphite Technologies Inc., an exploration stage company, focuses on the acquisition, exploration, and development of graphite related mineral properties primarily in the United States.

Titan Pharmaceuticals, Inc. (OTCBB: TTNP) showed no change, close at $0.625 with the overall traded volume of 315.366 shares.

So far, in the past three months, the stock is up 33.26%. The 52-week range for the stock is $0.32 and $2.53 and during the previous trading session the stock was found to mark $0.65 as its peak price. It kicked off the trading day with $0.62.

Can Investors Bet on TTNP after this News update? Find Out Here

Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.

About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/